RE: Vaccine effectiveness30 Nov 2021 18:10
story from PRO ACTIVE today''
The chief executive of Moderna Therapeutics Inc (NASDAQ:MRNA) has predicted that existing vaccines will be less effective against the Omicron variant than other strains of coronavirus.
In an interview with the Financial Times, Stéphane Bancel said the high number of Omicron mutations on the spike protein and the rapid spread of the variant in South Africa suggest that existing vaccines may need to be modified, which could take months.
“There is no world, I think, where [the effectiveness] is the same level?.?.?. we had with [the] Delta [variant],” Bancel said.
“I think it’s going to be a material drop.”
that is really good news for SAR 1801 for the spike in any Variant